New Millennium Group’s Novo Nordisk NVO Stock Holding History

New Millennium Group’s Portfolio NVO Stock Details NVO Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q4	$2.34K	Hold	46	–	–	﹤0.01%	289
2025 Q3	$2.55K	Hold	46	–	–	﹤0.01%	303
2025 Q2	$3.17K	Hold	46	–	–	﹤0.01%	291
2025 Q1	$3.19K	Hold	46	–	–	﹤0.01%	299
2024 Q4	$3.96K	Hold	46	–	–	﹤0.01%	322
2024 Q3	$5.48K	Hold	46	–	–	﹤0.01%	221
2024 Q2	$6.57K	Buy	+46	New	+$6.1K	﹤0.01%	214
2024 Q1	–	Sell	-46	Closed	-$4.76K	–	286
2023 Q4	$4.76K	Hold	46	–	–	﹤0.01%	248
2023 Q3	$4.18K	Hold	46	–	–	﹤0.01%	221
2023 Q2	$3.72K	Hold	46	–	–	﹤0.01%	236
2023 Q1	$3.66K	Hold	46	–	–	﹤0.01%	257
2022 Q4	$3.11K	Buy	+46	New	+$2.7K	﹤0.01%	273

Other funds holding NVO

Loomis, Sayles & Company Boston, Massachusetts $74.3B AUM 24.01% 1-Year Est. Return

Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return

Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return

Folketrygdfondet Oslo Norway, Norway $5.64B AUM 47.16% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Fisher Asset Management Camas, Washington $295B AUM 31.6% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

New Millennium Group's NVO Position: Q4 2025 in Review

New Millennium Group held its Novo Nordisk (NVO) position steady in Q4 2025 at 46 shares worth $2.34K. The position accounts for ﹤0.01% of the portfolio, ranked #289.

New Millennium Group first reported a position in NVO in Q4 2022 and has held it in 12 quarters since. The position peaked at $6.57K in Q2 2024. 1,413 funds tracked by Wall St. Rank hold NVO as of Q4 2025.

New Millennium Group held 46 shares of Novo Nordisk worth $2.34K as of Q4 2025.
New Millennium Group left its Novo Nordisk share count unchanged in Q4 2025.
Novo Nordisk made up ﹤0.01% of New Millennium Group's portfolio in Q4 2025, its #289 holding.
New Millennium Group first reported a position in Novo Nordisk in Q4 2022 and has held it in 12 quarters since.
New Millennium Group's Novo Nordisk position peaked at $6.57K in Q2 2024.
1,413 funds tracked by Wall St. Rank held Novo Nordisk as of Q4 2025.

Based on New Millennium Group's 13F filing for Q4 2025, filed 6 Feb 2026.